Validation and functional characterization of GWAS-identified variants for chronic lymphocytic leukemia: a CRuCIAL study
This work was partially supported by the European Union’s Horizon 2020 research and innovation program (grant No 856620); grants from the Instituto de Salud Carlos III (Madrid, Spain; PI17/02256 and PI20/01845); Consejería de Economía, Conocimiento, Empresas y Universidad (Granada, Spain; A-CTS-448-...
| Autores: | , , , , , |
|---|---|
| Tipo de recurso: | artículo |
| Estado: | Versión publicada |
| Fecha de publicación: | 2022 |
| País: | España |
| Institución: | Universitat Pompeu Fabra |
| Repositorio: | Repositorio Digital de la UPF |
| OAI Identifier: | oai:repositori.upf.edu:10230/54320 |
| Acceso en línea: | http://hdl.handle.net/10230/54320 http://dx.doi.org/10.1038/s41408-022-00676-8 |
| Access Level: | acceso abierto |
| Palabra clave: | Leucèmia limfoide Immunologia |
| Sumario: | This work was partially supported by the European Union’s Horizon 2020 research and innovation program (grant No 856620); grants from the Instituto de Salud Carlos III (Madrid, Spain; PI17/02256 and PI20/01845); Consejería de Economía, Conocimiento, Empresas y Universidad (Granada, Spain; A-CTS-448-UGR18); Consejería de Transformación Económica, Industria, Conocimiento y Universidades (Sevilla, Spain; PY20/01282); Generalitat de Catalunya (17SGR437); Gilead Sciences Fellowship (GLD17/00282); the “Xarxa de Bancs de tumors“ sponsored by Pla Director d’Oncologia de Catalunya (XBTC); the Associazione Italiana per la Ricerca sul Cancro and Fondazione Cariplo (TRIDEO 16923 and AIRC IG21436); the Spanish Association Against Cancer (AECC) Scientific Foundation grant GCTRA18022MORE; and the Consortium for Biomedical Research in Epidemiology and Public Health (CIBERESP), action Genrisk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. |
|---|